T1845 - TEZEPELUMAB [110 MG/ML 1,91 ML CANETA/SERINGA]
TED · 762133-2026Award noticeawardedNo deadline given
Value
Estimated€255,091 · 255,091.2 EUR
Awarded—
WinnerASTRAZENECA- PROD.FARM LDA
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde Santa Maria, E.P.E. in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ROCHE Farmacêutica Química, LDA | 35 | — | 2026-10-27 |
| GILEAD SCIENCES, LDA | 32 | — | 2026-11-03 |
| SANOFI-PRODUTOS FARMACÊUTICOS,LDA | 25 | €1,569,649 | 2026-11-03 |
| JANSSEN-CILAG FARMACEUTICA LDA | 19 | €371,730 | 2026-10-13 |
| NOVARTIS FARMA - PROD.FARM SA | 19 | — | 2026-10-20 |
Full buyer profile: what Unidade Local de Saúde Santa Maria, E.P.E. buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
TEZEPELUMAB [110 MG/ML 1,91 ML CANETA/SERINGA]
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-07-21 | 2024/0899 - MEPOLIZUMAB [100 MG/1 ML SOL INJ CANETA] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 94% |
| 2026-09-08 | 2024/0899 - BENRALIZUMAB [30 MG/1 ML SOL INJ CANETA/ SERINGA] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |
| 2026-07-28 | 2023/0491 - LANADELUMAB [300 MG/2 ML SOL INJ SERINGA] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |
| 2026-09-15 | 2023/0491 - BRODALUMAB [210 MG/ 1.5 ML SOL INJ SERINGA] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |
| 2026-10-27 | N190 - NATALIZUMAB [150 MG/ 1 ML SOL INJ SERINGA] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |
| 2026-09-08 | 2023/0491 - OFATUMUMAB [20 MG/0.4 ML SOL INJ CANETA] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |